Matthew D. Shair,Henry Efrem Pelish,Ioana IIinca Nitulescu
申请号：
US15807277
公开号：
US20180135134A1
申请日:
2017.11.08
申请国别(地区):
US
年份:
2018
代理人:
摘要：
A method for the targeted selection and treatment of patients with a tumor or cancer, comprising (i) determining whether the patient has a RUNX1 pathway impairment； and if so (ii) administering an effective amount of a cortistatin or its pharmaceutically acceptable salt or oxide, optionally in a pharmaceutically acceptable composition.
